Severe COVID-19 and inactivated vaccine in diabetic patients with SARS-CoV-2 infection
Authors:
Open Access
- 23 April 2025
- journal article
- other
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 138 (10) , 1257-1259
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysisDiabetologia, 2023
- Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational studyThe Lancet Infectious Diseases, 2022
- Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysisInfectious Diseases of Poverty, 2021
- Effectiveness of an Inactivated SARS-CoV-2 Vaccine in ChileNew England Journal of Medicine, 2021
- Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studiesNutrition, Metabolism and Cardiovascular Diseases, 2020